Population Pharmacokinetic-Pharmacodynamic Modeling of Variable Wear Times for a Dextroamphetamine Transdermal System

被引:1
|
作者
Castelli, Mariacristina [1 ]
Komaroff, Marina [1 ]
Meeves, Suzanne [1 ]
Balakrishnan, Kanan [1 ]
Baron, Kyle T. [2 ]
Mondick, John T. [2 ]
Faraone, Stephen V. [3 ,4 ]
Mattingly, Gregory W. [5 ]
机构
[1] Noven Pharmaceut Inc, Prod Dev, Jersey City, NJ USA
[2] Metrum Res Grp, Tariffville, CT USA
[3] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY USA
[4] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY USA
[5] Washington Univ, Midwest Res Grp, Sch Med, St Louis, MO USA
关键词
D O I
10.1017/S1092852923001827
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [1] POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF VARIABLE WEAR TIMES FOR A DEXTROAMPHETAMINE TRANSDERMAL SYSTEM
    Meeves, Suzanne
    Castelli, Mariacristina
    Komaroff, Marina
    Balakrishnan, Kanan
    Baron, Kyle T.
    Mondick, John T.
    Faraone, Stephen V.
    Mattingly, Gregory W.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 61 (10): : S228 - S228
  • [2] Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia
    Zoubir Djerada
    Catherine Feliu
    Yoann Cazaubon
    Faouzi Smati
    Philippe Gomis
    Dominique Guerrot
    Beny Charbit
    Olivier Fernandes
    Jean-Marc Malinovsky
    Clinical Pharmacokinetics, 2018, 57 : 1135 - 1147
  • [3] Population pharmacokinetic-pharmacodynamic modeling of spinal anesthesia with ropivacaine
    Djerada, Z.
    Feliu, C.
    Cazaubon, Y.
    Smati, F.
    Gomis, P.
    Charbit, B.
    Fernandes, O.
    Malinovsky, J. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 18 - 18
  • [4] Population Pharmacokinetic-Pharmacodynamic Modeling of Ropivacaine in Spinal Anesthesia
    Djerada, Zoubir
    Feliu, Catherine
    Cazaubon, Yoann
    Smati, Faouzi
    Gomis, Philippe
    Guerrot, Dominique
    Charbit, Beny
    Fernandes, Olivier
    Malinovsky, Jean-Marc
    CLINICAL PHARMACOKINETICS, 2018, 57 (09) : 1135 - 1147
  • [5] Pharmacokinetic-pharmacodynamic modeling:: Why?
    Pérez-Urizar, J
    Granados-Soto, V
    Flores-Murrieta, FJ
    Castañeda-Hernández, G
    ARCHIVES OF MEDICAL RESEARCH, 2000, 31 (06) : 539 - 545
  • [6] Pharmacokinetic-pharmacodynamic modeling of opioids
    Lötsch, JR
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : S90 - S103
  • [7] PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PAIN
    Loetsch, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 14 - 14
  • [8] Pharmacokinetic-Pharmacodynamic Modeling of Apratastat: A Population-Based Approach
    Shu, Cathye
    Zhou, Honghui
    Afsharvand, Mehri
    Duan, Larry
    Zhang, Hui
    Noveck, Robert
    Raible, Donald
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (04): : 472 - 481
  • [9] Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats
    Gopalakrishnan, M
    Suarez, S
    Hickey, AJ
    Gobburu, J
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2005, 32 (3-4) : 485 - 500
  • [10] Population Pharmacokinetic-Pharmacodynamic Modeling of Intrathecal Ropivacaine in Orthopedic Patients
    Gaudreault, Francois
    Drolet, Pierre
    Fallaha, Michel
    Varin, France
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S95 - S95